Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share

The following common stock equivalents were excluded from the calculation of diluted net loss per share applicable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

 

 

As of September 30,

 

 

 

2020

 

 

2019

 

Stock options

 

 

5,549,290

 

 

 

4,651,250

 

Unvested restricted stock units

 

 

1,694,633

 

 

 

1,108,691

 

Warrants*

 

 

2,145,642

 

 

 

2,118,094

 

Convertible preferred stock **

 

 

 

 

 

666,000

 

Total

 

 

9,389,565

 

 

 

8,544,035

 

 

* As of September 30, 2020, this is comprised of 2,118,094 warrants to purchase common stock issued in connection with the Company’s April 2019 financing (refer to Note 10) and 27,548 warrants to purchase common stock issued in connection with the execution of the Loan Agreement in February 2020 (refer to Note 7). As of September 30, 2019, this was comprised solely of 2,118,344 warrants to purchase common stock issued in connection with the Company’s April 2019 financing.

** In November 2019, the 666 shares of preferred stock issued in connection with the Company’s April 2019 financing were converted into 666,000 shares of common stock.